Twenty years after: from Milan criteria to a “blended” approach

Sandri, Giovanni Battista Levi; Lai, Quirino

doi:10.21037/tgh.2017.07.01

Cited by 2 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Liver transplantation (LT) is a curative option for both hepatocellular carcinoma (HCC) and cirrhosis. Twenty years after first Milan criteria (MC) description, they are still identified as the benchmark for selection of patients and set the baseline of survival to achieve (1). When MC was first proposed in 1996, they rapidly became the keystone for the selection of patients with HCC waiting for LT (2).…”

Section: Introductionmentioning

confidence: 99%

Liver transplant for patients outside Milan criteria

Sandri¹,

Rayar

Qi³

et al. 2018

Transl. Gastroenterol. Hepatol

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is one of the most indication to Liver Transplantation (LT). Milan criteria are worldwide accepted as the gold standard for LT indication for HCC. Nevertheless, expanded criteria are often used to transplant patient outside Milan. We described the most important proposed criteria outside Milan criteria. From the University of California San Francisco, to the Toronto criteria. From East to Western, and for living donor liver transplantation. In order to achieve similar results the downstaging strategy is more frequently used and for patients with locally advanced HCC. Carefully selected patients beyond the traditional criteria for transplantation may achieve excellent LT outcomes through a planned, multidisciplinary approach to treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Liver transplant for patients outside Milan criteria

Sandri¹,

Rayar

Qi³

et al. 2018

Transl. Gastroenterol. Hepatol

View full text Add to dashboard Cite

show abstract

“…Liver transplantation (LT) is the unique curative treatment for both Hepatocellular carcinoma (HCC) and liver cirrhosis. Twenty years have passed since the Milan criteria indicated how to select the best HCC candidates for LT (1). In the present focused issue we have underlined all the most recent evolutions in the field of LT for HCC.…”

mentioning

confidence: 99%